CD4 and prostate cancer: The presence of CD4+ CD25high regulatory T cells (Tregs) in the tumor and blood of cancer patients predicts poor prognosis and Tregs are significantly increased in the bone marrow of patients with prostate cancer that has metastasized to the bone [288].